Lung Cancer Nucleic Acid Test Clinicals Under Development By DiagnoCure
This article was originally published in The Gray Sheet
Executive Summary
DiagnoCure says its R&D collaboration with Compugen Ltd. will spur the launch of pivotal clinical studies evaluating a nucleic acid-based test for lung cancer by mid-2003